Advances in Laboratory Medicine·Mar 19Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patientsCohort study of 30 peopleHepatocellular carcinomaPaper
Liver International·Mar 13Hepatocellular Carcinoma in Egypt in the Post HCV Elimination Era: Changing Aetiology, Surveillance, and Management PathwaysReviewHepatocellular carcinomaPaper
Molecular Biomedicine·Mar 11Development and validation of a high-confidence diagnostic model integrating ctDNA methylation and serum biomarkers for early-stage hepatocellular carcinoma detectionCohort study of 1,692 peopleHepatocellular carcinomaPaper
Clinical and Molecular Hepatology·Feb 26GAFAD: A liquid chromatography-tandem mass spectrometry-based model for early hepatocellular carcinoma detection beyond GALAD's limitationsCohort study in peopleHepatocellular carcinomaPaper
Clinics·Feb 19Validation of the GALAD model for diagnosing HBV-related hepatocellular carcinoma in Chinese patientsCohort study of 247 peopleBiomarkersPaper
World Journal of Gastroenterology·Feb 16Refining early detection of hepatocellular carcinoma: The promise of the GALAD scoreCommentaryHepatocellular carcinomaPaper
Liver Cancer·Feb 2Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi PanelReviewHepatocellular carcinomaPaper
Gastroenterology·Jan 20Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled TrialRandomized trial in 1,208 peopleHepatocellular carcinomaPaper
Aging·Mar 22Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample sizeMeta-analysisHepatocellular carcinomaPaper